Singapore: OriGene Technologies, genome wide product company for research and diagnostic applications, acquired all the ...
As Chinese pharma moves forward to become the second largest market in the world by 2015, commercial operations for the ...
Singapore: Life science experts in China have called for more effective regulation in the domain of stem cell treatments...
For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As p...
Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, has been selected by the Beijing...
Singapore: BGI Tech Solutions has introduced its novel assembly solution for facilitating heterozygous genomes research....
Singapore: The chief executive officer of Sanjing Pharmaceutical, China, Mr Liu Zhanbin jumped to his death according to...
Singapore: In the first such case reported worldwide, a Chinese father is suspected to have transmitted the novel avian ...
Guangzhou Pharmaceutical Holdings owns stakes in two companies, Guangzhou Pharmaceutical and Guangzhou Baiyunshan Pharma...
Singapore: US based Targos, clinical biomarker service provider has signed a collaboration deal with China's WuXi Pharma...
The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month...
Singapore: AstraZeneca has established a joint venture (JV) with WuXi AppTec, China, to develop a new biotech medicine. ...
Singapore: BGI-Shenzhen (BGI) announced that its wholly-owned subsidiary Beta Acquisition, has extended its all cash te...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The Tibetan Ministry of Agriculture revealed on Tuesday, May 14, 2013, that a fresh outbreak of the older str...
Singapore: Issuing a statement to the media confirming a probe at its Chinese offices, German drug giant Bayer has now s...
Singapore: US-based Oncobiologics has signed an alliance agreement with China-based Zhejiang Huahai Pharmaceutical for t...
Singapore: The Bristol-Myers Squibb Foundation has awarded four new grants totaling $1.69 million to improve prevention,...
